Kestra Medical Technologies, Ltd. KMTS
27.14
1.38
5.36%
as of 25 Sep
- Market cap
- $1.5B
- P/E
- 0.0×
Follow KMTS
Insider Buys
alert about insiders buying in the last 12 month
| Older periods | Oct '25 | Jan '26 | Apr '26 | Jul '26 | |
|---|---|---|---|---|---|
|
+6 more TTM periods Free account |
0.00% | (366.07%) | (56.60%) | (73.74%) | |
| (109.08%) | (75.86%) | (40.24%) | (48.85%) | ||
ROIC |
(271.86%) | (235.95%) | (79.54%) | (93.49%) | |
Return on Tangible Assets |
(65.45%) | (44.28%) | (56.96%) | (62.02%) | |
Average Days of Receivables |
51.18 | 55.41 | 55.80 | 52.69 | |
Free Cash Flow per Share |
(2.22) | (2.15) | (2.16) | (2.10) | |
Free Cash Flow |
(114.18) | (120.01) | (116.94) | (123.06) | |
Capital Expenditures |
(27.51) | (32.97) | (35.24) | (35.34) | |
Piotroski F-Score |
1.00 | 1.00 | 4.00 | 3.00 | |
| Other line items | |||||
Cash ROIC |
(22.73%) | (14.00%) | (16.38%) | (17.77%) | |
Accounts Receivable Turnover |
0.00 | 11.39 | 8.41 | 8.66 | |
Accounts Payable Turnover |
0.00 | 1.79 | 1.81 | 2.21 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
185.32 | 204.36 | 215.35 | 192.53 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
28.24% | 26.98% | 20.48% | 20.87% | |
Selling, General and Administrative Expense of Revenue |
196.99% | 197.31% | 172.53% | 167.49% | |
Share Based Compensation of Revenue |
48.48% | 54.53% | 35.37% | 36.15% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.64 | 0.60 | 0.62 | 0.59 | |
Depreciation/Fixed assets |
0.21 | 0.19 | 0.18 | 0.16 | |
Capex/Depreciation |
(2.86) | (3.30) | (3.36) | (3.48) | |
Revenue per Share |
1.45 | 1.50 | 1.76 | 1.82 | |
Operating CF per Share |
(1.69) | (1.56) | (1.51) | (1.50) | |
Capex per Share |
(0.54) | (0.59) | (0.65) | (0.60) | |
Capex to Sales |
0.37 | 0.39 | 0.37 | 0.33 | |
Net Profit Margin |
(181.20%) | (171.87%) | (138.36%) | (140.43%) |
Columns are period end dates